TransUnion (TRU)

NYSE: TRU · IEX Real-Time Price · USD
58.32
-0.39 (-0.66%)
Mar 27, 2023, 4:00 PM EDT - Market closed

Stock Price Forecast

According to 23 stock analysts, the average 12-month stock price forecast for TransUnion stock is $82.37, which predicts an increase of 41.24%. The lowest target is $70.7 and the highest is $105. On average, analysts rate TransUnion stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $70.7 $82.37 $81.6 $105
Change +21.23% +41.24% +39.92% +80.04%

Analyst Ratings

The average analyst rating for TransUnion stock from 23 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '22Nov '22Dec '22Jan '23Feb '23Mar '23
Strong Buy 555556
Buy 109981010
Hold 888987
Sell 000000
Strong Sell 000000
Total 232222222323

Financial Forecast

Revenue This Year
3.88B
from 3.71B
Increased by 4.48%
Revenue Next Year
4.20B
from 3.88B
Increased by 8.28%
EPS This Year
3.56
from 1.40
Increased by 154.21%
EPS Next Year
4.20
from 3.56
Increased by 18.11%
Year 201820192020202120222023202420252026
Revenue
2.32B2.46B2.53B2.96B3.71B3.88B4.20B4.57B4.92B
Revenue Growth
19.83%
6.30%
2.74%
16.98%
25.33%
4.48%
8.28%
8.96%
7.48%
EPS
1.451.811.797.191.403.564.204.985.61
EPS Growth
-37.50%
24.83%
-1.10%
301.68%
-80.53%
154.21%
18.11%
18.45%
12.58%
No. Analysts -----2121122

Revenue Forecast

Revenue 2023202420252026
High 4.1B 4.5B 4.9B 5.1B
Avg 3.9B 4.2B 4.6B 4.9B
Low 3.7B 4.0B 4.3B 4.8B

Revenue Growth

Revenue Growth 2023202420252026
High
9.7%
16.0%
17.4%
11.7%
Avg
4.5%
8.3%
9.0%
7.5%
Low
0.2%
3.5%
1.5%
4.3%

EPS Forecast

EPS 2023202420252026
High 3.89 4.62 5.57 5.83
Avg 3.56 4.20 4.98 5.61
Low 3.20 3.86 4.58 5.44

EPS Growth

EPS Growth 2023202420252026
High
177.5%
29.8%
32.4%
17.0%
Avg
154.2%
18.1%
18.5%
12.6%
Low
128.9%
8.5%
8.9%
9.2%
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.